These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10914104)

  • 21. Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots.
    Hope VD; Hickman M; Ngui SL; Jones S; Telfer M; Bizzarri M; Ncube F; Parry JV
    J Viral Hepat; 2011 Apr; 18(4):262-70. PubMed ID: 20456636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood-borne virus infections among Australian injecting drug users: implications for spread of HIV.
    Crofts N; Hopper JL; Milner R; Breschkin AM; Bowden DS; Locarnini SA
    Eur J Epidemiol; 1994 Dec; 10(6):687-94. PubMed ID: 7672048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of hepatitis C in an ethnically diverse HIV-1-infected cohort in south London.
    Mohsen AH; Murad S; Easterbrook PJ
    HIV Med; 2005 May; 6(3):206-15. PubMed ID: 15876288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid spread of hepatitis C virus among injecting-drug users in the Philippines: Implications for HIV epidemics.
    Agdamag DM; Kageyama S; Alesna ET; Solante RM; Leaño PS; Heredia AM; Abellanosa-Tac-An IP; Vibal ET; Jereza LD; Ichimura H
    J Med Virol; 2005 Oct; 77(2):221-6. PubMed ID: 16121359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changing serological status and low vaccination-induced protection rates against hepatitis B characterize chronic hepatitis C virus-infected injecting drug users in Greece: need for immunization policy.
    Elefsiniotis IS; Pantazis KD; Ketikoglou ID; Koutsounas SI; Tsianos EV
    Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1227-31. PubMed ID: 17033445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of hepatitis C virus infection and associated factors among male illicit drug users in Cuiabá, Mato Grosso, Brazil.
    Novais AC; Lopes CL; Reis NR; Silva AM; Martins RM; Souto FJ
    Mem Inst Oswaldo Cruz; 2009 Sep; 104(6):892-6. PubMed ID: 19876562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High prevalence of genotype 4 among hepatitis C virus-infected intravenous drug users in north-eastern Poland.
    Chlabicz S; Flisiak R; Kowalczuk O; Wiercińska-Drapalo A; Pytel-Krolczuk B; Prokopowicz D; Chyczewski L
    J Med Virol; 2008 Apr; 80(4):615-8. PubMed ID: 18297715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evolutionary characteristics and positive selection site of hepatitis C virus isolated in intravenous drug users in Pudong new district, Shanghai].
    Wang Y; Wu HY; Zhao XC; Zhu WP; Wan Q; Lu YH; Jiang QW
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Mar; 38(3):378-383. PubMed ID: 28329944
    [No Abstract]   [Full Text] [Related]  

  • 29. Hepatitis C seroprevalence amongst injecting drug users attending a methadone programme.
    Chetwynd J; Brunton C; Blank M; Plumridge E; Baldwin D
    N Z Med J; 1995 Sep; 108(1007):364-6. PubMed ID: 7566775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis C virus infection in South Australian prisoners: seroprevalence, seroconversion, and risk factors.
    Miller ER; Bi P; Ryan P
    Int J Infect Dis; 2009 Mar; 13(2):201-8. PubMed ID: 18790659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High incidence of hepatitis C virus reinfection within a cohort of injecting drug users.
    Micallef JM; Macdonald V; Jauncey M; Amin J; Rawlinson W; van Beek I; Kaldor JM; White PA; Dore GJ
    J Viral Hepat; 2007 Jun; 14(6):413-8. PubMed ID: 17501762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C virus (HCV) serotype in the asymptomatic HCV-infected patients from selected groups.
    Pawłowska M; Halota W; Bulik F; Topczewska-Staubach E
    Arch Immunol Ther Exp (Warsz); 1997; 45(5-6):455-7. PubMed ID: 9437502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
    Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M
    BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis C antibody prevalence among Mexico City prisoners injecting legal and illegal substances.
    Silverman-Retana O; Serván-Mori E; McCoy SI; Larney S; Bautista-Arredondo S
    Drug Alcohol Depend; 2017 Dec; 181():140-145. PubMed ID: 29054033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High prevalence of HBV and HCV infection among intravenous drug users in Korea.
    Yun H; Kim D; Kim S; Kang S; Jeong S; Cheon Y; Joe K; Gwon DH; Cho SN; Jee Y
    J Med Virol; 2008 Sep; 80(9):1570-5. PubMed ID: 18649342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distribution of hepatitis C virus genotypes among injecting drug users in contact with treatment centers in Belgium, 2004-2005.
    Micalessi MI; Gérard C; Ameye L; Plasschaert S; Brochier B; Vranckx R
    J Med Virol; 2008 Apr; 80(4):640-5. PubMed ID: 18297717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A national survey of genitourinary medicine clinic attenders provides little evidence of sexual transmission of hepatitis C virus infection.
    Balogun MA; Ramsay ME; Parry JV; Donovan L; Andrews NJ; Newham JA; McGarrigle C; Harris KA; Teo CG
    Sex Transm Infect; 2003 Aug; 79(4):301-6. PubMed ID: 12902580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors.
    Loebstein R; Mahagna R; Maor Y; Kurnik D; Elbaz E; Halkin H; Olchovsky D; Ezra D; Almog S
    Isr Med Assoc J; 2008 Nov; 10(11):775-8. PubMed ID: 19070285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Never injected, but hepatitis C virus-infected: a study among self-declared never-injecting drug users from the Amsterdam Cohort Studies.
    van den Berg CH; van de Laar TJ; Kok A; Zuure FR; Coutinho RA; Prins M
    J Viral Hepat; 2009 Aug; 16(8):568-77. PubMed ID: 19243497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence of multiple hepatitis virus infections in autopsied materials of intravenous drug addicts.
    Schleicher S; Schieffer M; Jürgens S; Wehner HD; Flehmig B
    Ig Sanita Pubbl; 2005; 61(5):435-50. PubMed ID: 17214028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.